You may also like
Anticoagulation Management in Severe Coronavirus Disease 2019 Patients on Extracorporeal Membrane Oxygenation
Hypercoagulability and secondary hyperfibrinolysis during ECMO support in COVID-19 patients are common and possibly increase the propensity for thrombotic events and failure of the oxygenator. Currently, there is not enough evidence to support a more aggressive anticoagulation strategy.
1 min read
ERaaS Chart Review System (EP Video)
James Reagor discusses the ERaaS Chart Review System designed for an external review of your hospital charts (07:42 minutes).
1 min read
Experience with Intravenous Ferric Carboxymaltose in Patients with Iron Deficiency Anemia
Ferric carboxymaltose (FCM) is a nondextran iron preparation recently approved in the United States for intravenous treatment of iron deficiency anemia (IDA) in adult patients with intolerance or unsatisfactory response to oral iron or with nondialysis-dependent chronic kidney disease.
1 min read
